Based on the outcomes of pathway enrichment, SM and RP active ingredients can simultaneously target cancer pathways, neuroactive ligand-receptor interactions, and PI3K-Akt and TNF signaling pathways, leading to the synergistic effect of SM and RP. Here, AKT1 is linked to cancer.